— Know what they know.
Not Investment Advice

PGNY NASDAQ

Progyny, Inc.
1W: +8.0% 1M: +37.2% 3M: +17.7% YTD: -4.1% 1Y: +12.9% 3Y: -31.3% 5Y: -51.1%
$24.88
+0.19 (+0.77%)
 
Weekly Expected Move ±12.8%
$17 $20 $23 $26 $29
NASDAQ · Healthcare · Medical - Healthcare Information Services · Alpha Radar Buy · Power 70 · $1.9B mcap · 72M float · 2.28% daily turnover · Short 54% of daily vol

Revenue Segmentation

By Product / Service

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$1.3B +10.4% ▲
5Y CAGR: +30.2%
Gross Profit
$304M +20.2% ▲
5Y CAGR: +34.2%
Operating Income
$85M +26.4% ▲
5Y CAGR: +59.2%
Net Income
$59M +7.7% ▲
5Y CAGR: +4.7%
EPS (Diluted)
$0.65 +14.0% ▲
5Y CAGR: +6.7%
EBITDA
$100M +42.1% ▲
5Y CAGR: +57.8%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$501M$787M$1.1B$1.2B$1.3B
YoY Growth+45.2%+57.2%+38.3%+7.2%+10.4%
Cost of Revenue$388M$620M$850M$914M$984M
Gross Profit$112M$167M$239M$253M$304M
Gross Margin22.4%21.3%21.9%21.7%23.6%
R&D Expenses$0$0$0$0$0
SG&A Expenses$80M$144M$177M$186M$219M
Operating Expenses$80M$144M$177M$186M$219M
Operating Income$32M$23M$62M$67M$85M
Operating Margin6.5%3.0%5.7%5.8%6.6%
Interest Expense$0$0$0$0$0
Income Before Tax$32M$24M$71M$83M$95M
Tax Expense-$33M-$6M$9M$29M$37M
Net Income$66M$30M$62M$54M$59M
Net Margin13.1%3.9%5.7%4.7%4.5%
EPS (Diluted)$0.66$0.30$0.62$0.57$0.65
EBITDA$34M$25M$64M$71M$100M
Shares Outstanding100M100M101M95M89M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms